|
药品质量源于设计 工程经验来自实践
分享全球顶级智慧 把脉中国制药工程
鉴于中国制药工程领域的整体水平仍然偏低，而工程设计则是其中的一大薄弱环节，设计不到位也导致项目实施过程中经常出现边施工边修改的情况，造成诸多的项目延期、成本损失等。而一份良好的工程设计方案需要对前期准备工作进行充分的研究，需要各相关人员的提前介入，而工程设计的核心则是建立在对制药生产工艺、设备的深刻理解上。
鉴于这种现状，PROCESS《流程工业》定于2010年6月2~3日再度举办“2010制药工程国际论坛”，采取主会场、分论坛相结合的形式，邀请来自全球制药工程领域的专家带来20余场高品质的会议报告，从GMP法规、先进的制药工艺、制药设备、典型工程项目案例等方面与现场听众进行交流、探讨。
主会场将有来自美国FDA、欧盟EMEA、SFDA的官员带来“FDA的21世纪cGMP”，“EU最新cGMP法规解读”，“中国新版GMP介绍”等GMP相关法规政策；四个分论坛涉及主题分别为“固体制剂、无菌生产、生物制药、药厂自动化”，来自全球知名的工程服务公司、世界顶级的工艺、设备供应商，国内外药厂的专家将与听众分享其多年的工程、工艺经验，以及亚太区最新的项目案例。
这是一个专程为制药工程人士打造的全球价值分享和信息交流的开放式平台，这里，欢迎每一位制药工程领域的有志之士！
Considerations have been given to the fact that the overall
level of China’s pharmaceutical engineering industry remains
low, and engineering design is one major weak link in the
industry and unsophisticated design also results in
concurrent construction and modification frequently
occurring during project implementation and thus delay,
costs and losses in various projects. One excellent
engineering project proposal requires sufficient study of
preparations at the early stage and advanced involvement of
relevant personnel while the core of engineering design is
based on intimate understanding on pharmaceutical production
process and equipment.
In response to such current situation, 2010 Pharmaceutical
Engineering International Forum including main forum and
sub-fora is scheduled to be held by PROSECC magazine during
June 2-3, 2010, on which experts from global pharmaceutical
engineering industry will be invited to deliver more than 20
high-grade reports and discuss with the audience about GMP,
advanced pharmaceutical processes and equipment and typical
cases of projects etc.
Officials from U.S FDA, EU EMEA and SFDA will deliver
speeches on GMP-related laws, regulations and policies
entitled FDA’s the 21st cGMP，Analysis of EU’s latest cGMP
and China’s new version of GMP on main forum, while four
sub-fora deal with the subjects Solid Preparation, Sterile
Production, Biopharmaceuticals and Automation of
Pharmaceutical Factory. Experts from global famous
engineering service companies, the world-class process and
equipment suppliers and domestic and foreign pharmaceutical
factories will share with the audience many years of their
experience in engineering and process and the latest cases
of projects in Asia Pacific Region.
This is one open platform dedicated for global value sharing
and information exchange for personnel specializing in
pharmaceutical engineering. Those with noble aspirations
from pharmaceutical industry are welcome!
|
